Non-Euploid Embryo Transfer (NEET) Registry

The NEET Registry: a Prospective, Observational Study for Outcomes of Non-euploid Embryo Transfers (NEET)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07036536

Enrollment

1000

Registered

2025-06-25

Start date

2024-09-23

Completion date

2030-12-01

Last updated

2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneuploidy, Infertility, Mosaicism

Keywords

IVF, PGT-A, aneuploid, FET

Brief summary

The NEET Registry is a registry to track and study the outcomes of non-euploid embryo transfers (NEET) in The Prelude Network

Detailed description

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is widely offered as an option for patients pursuing pregnancy through in vitro fertilization (IVF). Most often, embryos with normal chromosome results are selected for transfer, with well established outcomes. However, for patient specific reasons, transferring an embryo with a non-euploid result (i.e. mosaic, isolated segmental aneuploid or aneuploidy of whole chromosome(s)) may be considered. Very little information is available on the long-term outcomes of mosaic embryo transfer. Even less has been published on outcomes for other types of non-euploid results. This study aims to collect prenatal, neonatal and pediatric outcome information for embryos transferred with the various types of non-euploid PGT-A results to better inform providers and patients in their decision making regarding such transfers.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Patient is planning a non-euploid embryo transfer (NEET) at a fertility clinic in The Prelude Network. * Patient has signed informed consent to participate in the registry.

Exclusion criteria

* Not applicable

Design outcomes

Primary

Measure	Time frame	Description
Rate of Embryo Implantation	5 years	The frequency of positive pregnancy test (blood serum QHCG) 10-14 days post embryo transfer

Countries

United States

Contacts

CONTACTLaurel Anderson

research@inceptionllc.com3463621476

Outcome results